Orofer S Injection contains Iron (50 mg) and is indicated for the treatment and prevention of iron deficiency anemia, particularly in cases where oral iron therapy is ineffective or contraindicated. This parenteral formulation provides a rapid and efficient means of replenishing iron stores in patients with iron deficiency due to chronic blood loss, nutritional deficiencies, or impaired absorption. Orofer S Injection is administered intramuscularly or intravenously under medical supervision, ensuring controlled delivery of elemental iron directly into the systemic circulation. The iron component plays a critical role in hemoglobin synthesis, oxygen transport, and various enzymatic processes essential for cellular metabolism. Careful patient evaluation is necessary prior to administration to exclude conditions such as iron overload or hypersensitivity to iron preparations. Adverse effects may include local injection site reactions, transient hypotension, nausea, or allergic responses, which should be promptly addressed. Dosage and duration of therapy are individualized based on the severity of anemia, patient weight, and response to treatment. Regular monitoring of hemoglobin levels and iron indices is recommended to assess therapeutic efficacy and prevent iron toxicity. Orofer S Injection is a valuable therapeutic option for rapid correction of iron deficiency anemia, improving patient outcomes and quality of life.